Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major

被引:113
作者
Louzir, H
Melby, PC
Ben Salah, A
Marrakchi, H
Aoun, K
Ben Ismail, R
Dellagi, K
机构
[1] Inst Pasteur, Lab Immunol LAF 301, Tunis 1002, Tunisia
[2] Inst Pasteur, Lab Epidemiol & Ecol Parasit Dis, Tunis 1002, Tunisia
[3] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
[4] VA Med Ctr, Med Serv, San Antonio, TX USA
关键词
D O I
10.1086/515297
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Localized cutaneous leishmaniasis caused by Leishmania major is polymorphic in its clinical presentation and evolution. Clinical and parasitologic features and disease evolution of 112 Tunisian patients was evaluated. The expression of interleukin (IL)-4, IL-6, IL-10, IL-12 (p40), interferon (IFN)-gamma, and tumor necrosis factor (TNF)-alpha mRNA was analyzed by reverse transcription-polymerase chain reaction in 73 biopsies. Cytokine mRNA expression varied individually over a wide range; TNF-alpha, IL-6, and IFN-gamma were detectable in >90% of lesions, IL-12 and IL-10 in 40% and 70%, respectively, and IL-4 in only 9%. Statistical analysis demonstrated positive association between the level of IL-12 and IFN-gamma and the presence of parasites in the lesions. Unfavorable evolution of the lesions was positively associated with high IL-10, IL-12, and IFN-gamma mRNA expression. These results indicate that an unfavorable clinical outcome was not related to an inadequate Th1 cell response and suggest that the macrophage-activating effect of IFN-gamma may be inhibited by the concomitant expression of IL-10.
引用
收藏
页码:1687 / 1695
页数:9
相关论文
共 47 条
[1]  
ALARD P, 1993, BIOTECHNIQUES, V15, P730
[2]   EXPRESSION AND SECRETION OF TYPE-BETA TRANSFORMING GROWTH-FACTOR BY ACTIVATED HUMAN MACROPHAGES [J].
ASSOIAN, RK ;
FLEURDELYS, BE ;
STEVENSON, HC ;
MILLER, PJ ;
MADTES, DK ;
RAINES, EW ;
ROSS, R ;
SPORN, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (17) :6020-6024
[3]  
BARRAL A, 1995, AM J PATHOL, V147, P947
[4]   TRANSFORMING GROWTH-FACTOR-BETA IN LEISHMANIAL INFECTION - A PARASITE ESCAPE MECHANISM [J].
BARRALNETTO, M ;
BARRAL, A ;
BROWNELL, CE ;
SKEIKY, YAW ;
ELLINGSWORTH, LR ;
TWARDZIK, DR ;
REED, SG .
SCIENCE, 1992, 257 (5069) :545-548
[5]  
Ben Ismail R., 1989, Maladies tropicales transmissibles., P73
[6]  
Ben Ismail R., 1987, PARASSITOLOGIA, V28, P186
[7]   EPIDEMIC CUTANEOUS LEISHMANIASIS IN TUNISIA - BIOCHEMICAL-CHARACTERIZATION OF PARASITES [J].
BENISMAIL, R ;
GRADONI, L ;
GRAMICCIA, M ;
BETTINI, S ;
BENRACHID, MS ;
GARRAOUI, A .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1986, 80 (04) :669-670
[8]   MACROPHAGE DEACTIVATION BY INTERLEUKIN-10 [J].
BOGDAN, C ;
VODOVOTZ, Y ;
NATHAN, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1549-1555
[9]   ESTABLISHMENT OF STABLE, CELL-MEDIATED-IMMUNITY THAT MAKES SUSCEPTIBLE MICE RESISTANT TO LEISHMANIA-MAJOR [J].
BRETSCHER, PA ;
WEI, GJ ;
MENON, JN ;
BIELEFELDTOHMANN, H .
SCIENCE, 1992, 257 (5069) :539-542
[10]  
CACERESDITTMAR G, 1993, CLIN EXP IMMUNOL, V91, P500, DOI 10.1111/j.1365-2249.1993.tb05931.x